Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2011-02-28
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise: A Novel Treatment for Combat Post Traumatic Stress Disorder
NCT01626131
Exercise and Therapeutic Learning Among Women With PTSD
NCT04113798
Treatment of Post-Traumatic Stress Disorder (PTSD) and Chronic Pain After Traumatic Orthopedic Injury
NCT00957164
Exercise and PTSD in Older Veterans
NCT02295995
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
NCT01998100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Imaginal Therapy Only
The imaginal exercise of exposure therapy will be manualized (Rothbaum, Foa \& Hembree, 2007) and adapted with the permission of Dr. Foa for combat-related stress disorders (Peterson, Cigrang \& Riggs, 2008). While traditional exposure therapy includes both imaginal exposure and in vivo exposure, this study will use only the imaginal exposure components. Participants will meet with a therapist the first week of treatment and every-other week for a total of five appointments over eight weeks. During the second session, the therapist will help the participant make an approximately 20-minute voice tape recording of their traumatic experience which they will listen to 5-days/week. A new recording will be made with the therapist during sessions 3 and 4 also, for a total of three tapes.
imaginal therapy
imaginal exercise of Prolonged Exposure therapy
Exercise Only
The aerobic exercise regimen will be standardized according to the American College of Sports Medicine recommendations: frequency of a minimum of 5 sessions per week, at a vigorous intensity \[\>60% of oxygen uptake reserve (VO2R)\], time of 20-25 minutes per exercise session. To determine the exercise heart rate intensity, the Karvonen formula for heart rate reserve will be used. The mode of exercise will be purposeful walking or jogging. The goal of the exercise is not training, but rather to keep the participant's heart rate \>60% of their individually-determined heart rate reserve.
exercise
aerobic training at a frequency of a minimum of 3 sessions per week, at vigorous intensity \[i. e., \>60% of oxygen uptake reserve (VO2R)\], and a time of 20-25 minutes each bout of training
Imaginal Therapy & Exercise Combined
Participants will meet with a therapist the first week of treatment and every-other week for a total of five appointments over eight weeks. During the second session, the therapist will help the participant make an approximately 20-minute voice tape recording of their traumatic experience which they will listen to 5-days/week. A new recording will be made with the therapist during sessions 3 and 4 also, for a total of three tapes. Participants will exercise listening to their tape at least 5-times/week outside of scheduled unit Physical Training. Participants will wear the heart rate monitor to record their exercise activity.
imaginal therapy
imaginal exercise of Prolonged Exposure therapy
exercise
aerobic training at a frequency of a minimum of 3 sessions per week, at vigorous intensity \[i. e., \>60% of oxygen uptake reserve (VO2R)\], and a time of 20-25 minutes each bout of training
Nurse-led Self-Care
The Self-Care Group will use written materials that outline the benefits of thinking about problems the individual is facing as well as the benefits of exercise, however doing the two activities together will not be advocated as part of the material. A fact sheet prepared by the National Center for PTSD, Returning from the War Zone: A Guide for Military Personnel as well as a list of coping strategies and self-care behaviors adapted from the National Center for PTSD guide, Self-Care and Self-Help Following Disasters, will be used to guide the discussion. The research nurse will meet with the participant five times over 8-weeks at weeks 1, 2, 4, 6, and 8 to encourage use of the self-care fact sheet and assess the participant for safety.
self-care
meeting with a nurse to review and discuss publically available written materials that outline approaches for dealing with posttraumatic stress symptoms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
imaginal therapy
imaginal exercise of Prolonged Exposure therapy
exercise
aerobic training at a frequency of a minimum of 3 sessions per week, at vigorous intensity \[i. e., \>60% of oxygen uptake reserve (VO2R)\], and a time of 20-25 minutes each bout of training
self-care
meeting with a nurse to review and discuss publically available written materials that outline approaches for dealing with posttraumatic stress symptoms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be at least 18 years old
* be able to read and speak English
* answer "no" to the seven questions of the Physical Activity Readiness Questionnaire (PAR-Q), or have primary care provider approval to undertake an exercise program.
* score ≥25 on the PTSD CheckList - Stressor-Specific(PCL-S); participants scoring \>50 on the PCL-S will be contacted weekly to ensure that their symptoms are under control and they do not require a higher level of care.
* report on the PTSD Symptom Scale - Interview (PSS-I) an exposure to a traumatic event (Criterion A), at least one re-experiencing symptom (Criterion B), and at least one avoidance symptom (Criterion C)
* participants taking psychotropic medications agree to work with their prescriber to remain on stable doses of any prescribed psychotropic medications for the duration of the intervention and through the 1-month follow-up assessment as much as possible and as medically indicated
* anticipate being in the area for at least three months to complete intervention and 13-week follow-up assessment
Exclusion Criteria
* have undergone exposure therapy for PTSD within the last year
* be taking benzodiazepines every day on a prescribed schedule (Individuals prescribed and taking a benzodiazepine only as needed will not be excluded.)
* suicidal ideation with moderate to severe intent warranting intervention
* active psychosis or mania
* be on a medical profile that prohibits exercise
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
C.R.Darnall Army Medical Center
FED
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacey Young-McCaughan, RN, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas Health Science Center San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carl R. Darnall Army Medical Center
Fort Hood, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
STRONG STAR Consortium web link describing study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC20100372H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.